Evidence map›Paper›PMID 33408786›Full record

ArticleTheranostics2021

Imaging atherosclerotic plaques by targeting Galectin-3 and activated macrophages using (

Zohreh Varasteh, Francesco De Rose, Sarajo Mohanta, Yuanfang Li, Xi Zhang, Benedikt Miritsch, Giorgia Scafetta, Changjun Yin, Hendrik B Sager, Sarah Glasl and 7 more

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Nanomedicine for Diagnosis and Treatment of Atherosclerosis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Review
  13. Article
  14. Role of galectin-3 in vascular calcification.Glycoconjugate journal · 2023
    Review
  15. Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?International journal of molecular sciences · 2022
    Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. In Vivo Imaging of Thyroid Cancer withJournal of clinical medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Zohreh VarastehDepartment of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.
Francesco De RoseDepartment of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.
Sarajo MohantaInstitute for Cardiovascular Prevention, University Hospital of Ludwig-Maximilians-University, Munich, Germany.
Yuanfang LiInstitute for Cardiovascular Prevention, University Hospital of Ludwig-Maximilians-University, Munich, Germany.
Xi ZhangInstitute for Cardiovascular Prevention, University Hospital of Ludwig-Maximilians-University, Munich, Germany.
Benedikt MiritschDepartment of Cardiology, German Heart Center Munich, Munich, Germany.
Giorgia ScafettaPathology Research Laboratory, St. Andrea University Hospital, Rome, Italy.
Changjun YinInstitute for Cardiovascular Prevention, University Hospital of Ludwig-Maximilians-University, Munich, Germany.
Hendrik B SagerDepartment of Cardiology, German Heart Center Munich, Munich, Germany.
Sarah GlaslInstitute of Biological and Medical Imaging, Helmholtz Zentrum München, Munich, Germany.
Dimitris GorpasInstitute of Biological and Medical Imaging, Helmholtz Zentrum München, Munich, Germany.
Andreas J R HabenichtInstitute for Cardiovascular Prevention, University Hospital of Ludwig-Maximilians-University, Munich, Germany.
Vasilis NtziachristosInstitute of Biological and Medical Imaging, Helmholtz Zentrum München, Munich, Germany.
Wolfgang A WeberDepartment of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.
Armando BartolazziPathology Research Laboratory, Cancer Center Karolinska, SE-17176 Stockholm, Sweden.
Markus SchwaigerDepartment of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.
Calogero D'AlessandriaDepartment of Nuclear Medicine, Klinikum rechts der Isar der TUM, Munich, Germany.
Klinikum rechts der Isar · DELudwig-Maximilians-Universität München · DECTO Andrea Alesini · ITDeutsches Herzzentrum München · DEInstitute of Biological and Medical ImagingHelmholtz Zentrum München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntibodies, MonoclonalDeferoxamineFemaleGalectin 3HumansMacrophagesMiceMice, Inbred C57BLMice, Knockout, ApoEPlaque, AtheroscleroticPositron-Emission TomographyRadioisotopesRadiopharmaceuticalsZirconiumAntibodies, MonoclonalDeferoxamineGalectin 3RadioisotopesRadiopharmaceuticalsZirconiumZirconium-89activated macrophagesAtherosclerotic plaquesGalectin-3InflammationPET/CT

Identifiers

PMID33408786
PMCPMC7778602
OpenAlexW3112657508

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.